These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 165518)

  • 1. Cytotoxic effector cells specific for B Cell lines transformed by Epstein-Barr virus are present in patients with infectious mononucleosis.
    Svedmyr E; Jondal M
    Proc Natl Acad Sci U S A; 1975 Apr; 72(4):1622-6. PubMed ID: 165518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
    Patel PC; Dorval G; Menezes J
    Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD8+ T cell subsets of cytotoxic T lymphocytes induced by Epstein-Barr virus infection in infectious mononucleosis.
    Ebihara T; Sakai N; Koyama S
    Tohoku J Exp Med; 1990 Nov; 162(3):213-24. PubMed ID: 1965352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell-mediated immunity to Epstein-Barr-virus-transformed lymphoblastoid cells in acute infectious mononucleosis.
    Royston I; Sullivan JL; Periman PO; Perlin E
    N Engl J Med; 1975 Dec; 293(23):1159-63. PubMed ID: 171568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EBV-related cytotoxicity of Fc receptor negative T lymphocytes separated from the blood of infectious mononucleosis patients.
    Bakacs T; Svedmyr E; Klein E
    Cancer Lett; 1978 Apr; 4(4):185-9. PubMed ID: 206347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reactivation of Epstein-Barr virus-specific cytotoxic T cells by in vitro stimulation with the autologous lymphoblastoid cell line.
    Rickinson AB; Moss DJ; Allen DJ; Wallace LE; Rowe M; Epstein MA
    Int J Cancer; 1981 May; 27(5):593-601. PubMed ID: 6169663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced destruction of lymphoid cell lines by peripheral blood leukocytes taken from patients with acute infectious mononucleosis.
    Hutt LM; Huang YT; Dascomb HE; Pagano JS
    J Immunol; 1975 Jul; 115(1):243-8. PubMed ID: 168255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibody-dependent cellular cytotoxicity (ADCC) against Epstein-Barr virus-determined membrane antigens. I. Reactivity in sera from normal persons and from patients with acute infectious mononucleosis.
    Jondal M
    Clin Exp Immunol; 1976 Jul; 25(1):1-5. PubMed ID: 186222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-carrying B cells in the blood during acute infectious mononucleosis give rise to lymphoblastoid lines in vitro by release of transforming virus and by proliferation.
    Lewin N; Aman P; Akerlund B; Gustavsson E; Carenfelt C; Lejdeborn L; Klein G; Klein E
    Immunol Lett; 1990 Oct; 26(1):59-65. PubMed ID: 2177451
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stimulation of normal lymphocytes with autologous lymphoid cell lines: properties of derived killer cells.
    Svedmyr E; Jondal M; Leibold W
    Scand J Immunol; 1975; 4(7):721-34. PubMed ID: 173017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reactivity of Paul-Bunnell type heterophile antibody in sera from infectious mononucleosis patients with the surface of lymphoid cells carrying Epstein-Barr virus genomes.
    Maeda M; Sairenji T; Hinuma Y
    Microbiol Immunol; 1979; 23(12):1189-97. PubMed ID: 231730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple HLA class I-dependent cytotoxicities constitute the "non-HLA-restricted" response in infectious mononucleosis.
    Strang G; Rickinson AB
    Eur J Immunol; 1987 Jul; 17(7):1007-13. PubMed ID: 2440688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of allogeneic restriction in human T-cell-mediated cytotoxicity to Epstein-Barr virus-infected target cells. Demonstration of an HLA-linked control at the effector level.
    Lipinski M; Fridman WH; Tursz T; Vincent C; Pious D; Fellous M
    J Exp Med; 1979 Dec; 150(6):1310-22. PubMed ID: 229186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein Barr virus-specific immune defects in patients with persistent symptoms following infectious mononucleosis.
    Borysiewicz LK; Haworth SJ; Cohen J; Mundin J; Rickinson A; Sissons JG
    Q J Med; 1986 Feb; 58(226):111-21. PubMed ID: 3012622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cytotoxicity of human T-lymphocytes sensitized by Epstein-Barr virus. Role of HLA antigens at the surface of target cells infected by the virus].
    Tursz T; Fridman WH; Tsapis A; Senik A; Fellous M
    C R Acad Hebd Seances Acad Sci D; 1977 May; 284(20):2063-6. PubMed ID: 196780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro expansion of Epstein-Barr virus-specific HLA-restricted cytotoxic T cells direct from the blood of infectious mononucleosis patients.
    Strang G; Rickinson AB
    Immunology; 1987 Dec; 62(4):647-54. PubMed ID: 2828228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective generation of killer cells against spontaneously Epstein-Barr virus (EBV)-transformed autologous B cells in a fatal EBV infection.
    Yanagisawa M; Kato M; Ikeno K; Kobayashi T; Miyagawa Y; Komiyama A; Akabane T
    Clin Exp Immunol; 1987 May; 68(2):251-8. PubMed ID: 2820633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mitotic EBNA-positive lymphocytes in peripheral blood during infectious mononucleosis.
    Robinson J; Smith D; Niederman J
    Nature; 1980 Sep; 287(5780):334-5. PubMed ID: 6252472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic T cell recognition of Epstein-Barr virus-infected B cells. III. Establishment of HLA-restricted cytotoxic T cell lines using interleukin 2.
    Wallace LE; Rowe M; Gaston JS; Rickinson AB; Epstein MA
    Eur J Immunol; 1982 Dec; 12(12):1012-8. PubMed ID: 6297919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the T cell-mediated cellular cytotoxicity during acute infectious mononucleosis.
    Tomkinson BE; Maziarz R; Sullivan JL
    J Immunol; 1989 Jul; 143(2):660-70. PubMed ID: 2472449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.